Rhythm Biosciences Ltd has released a press release.
Rhythm Receives $1.1m R&D Tax Incentive
Filed with ASX ·
6ix hasn’t read this filing yet.
Rhythm Biosciences Limited on 6ix
Earlier from Rhythm Biosciences
- Final Two Adjunct Biomarkers Technically Validated
- New Clinical Trial Site Contracted and Recruiting
- Rhythm Successfully Validates Two Adjunct Biomarkers
- Revised CEO Contract and LTIP for all employees - amended
- Revised CEO Contract and LTIP initiated for all employees
Later from Rhythm Biosciences
- Ethics Approval Received, New Clinical Trial Site Added
- ColoSTAT Prototype Complete, Outperforms FIT
- AGM Presentation - November 2020
- Rhythm Appoints Global Manufacturer for ColoSTAT
- Rhythm Secures US Patent - Strengthens Global Footprint
Follow Rhythm Biosciences into a list and get an email when it puts out news.
Follow Rhythm Biosciences